How much does a box of erdafitinib cost? Comparative analysis of prices of versions in different countries

Erdafitinib is a targeted drug used to treat cancers with FGFR mutations. Although it has been marketed in China, it has not yet been included in medical insurance. Due to its short time on the market, it may be difficult to purchase the drug directly, and many patients may choose to purchase it through foreign channels. The prices of versions in different countries vary greatly. Below we will compare the prices of domestic and foreign versions.

In China, the original drug of erdafitinib is already on the market, but because it has not yet been included in medical insurance, its price is relatively high. When patients purchase it through formal channels, the price per box may be as high as more than 20,000 yuan. Because erdafitinib is a newer drug, its supply in the Chinese market is relatively limited, and patients may have to wait a long time to purchase the drug. At the same time, the price of medicines may be slightly different in different regions, so patients need to understand the specific prices based on the actual situation and the situation of local pharmacies.

Hong Kong is one of the important markets for erdafitinib, and the Hong Kong version of the original drug is usually more expensive. The price of each box is about more than 20,000 yuan, which is slightly different from the domestic price. Patients can purchase it through pharmacies in Hong Kong, but they will need to bear additional logistics costs and possible customs duties. This purchasing method may be suitable for some patients who urgently need medication, but the price and delivery process may become a financial burden.
Compared with original drugs, the prices of generic drugs on foreign markets are relatively much cheaper, especially those produced in countries such as Laos and Bangladesh. Taking the Laos version and the Bangladesh Yaobin International version as examples, the price usually ranges from a few hundred yuan to more than 2,000 yuan. The ingredients of these generic drugs are basically the same as the original drugs, so for some patients with heavy financial burden, generic drugs have become a more economical choice. The quality of generic drugs has also received relevant international certifications, and patients can use them with confidence.
Taken together, the price of the domestic version of the original drug erdafitinib is higher, while the price of the Hong Kong version of the original drug is similar to that in China, which may further increase costs due to logistics and tariffs. In contrast, generic drugs in Laos and Bangladesh have obvious advantages in price, and their efficacy and ingredients are consistent with the original drugs. Therefore, if patients need to purchase through foreign channels, choosing generic drugs may be a more economical solution. However, when purchasing generic drugs, patients should ensure that they purchase them through formal channels to avoid purchasing counterfeit and substandard drugs.
Reference link: https://www.balversa.com/